CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 55,125 | ||
| 2025-09-02 | CAUSEY CHRISTOPHER Director | Exercise or conversion 10b5-1 | +3,000 | $132.30 | $397K | 7,865 |
| 2025-09-02 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $419.63 | $420K | 6,865 |
| 2025-09-02 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $430.00 | $430K | 5,865 |
| 2025-09-02 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $420.00 | $420K | 4,865 |
| 2025-09-02 | CAUSEY CHRISTOPHER Director | Exercise or conversion · Stock Option 10b5-1 | −3,000 | 0 | ||
| 2025-09-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −600 | $304.57 | $183K | 47,181 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −300 | $306.12 | $92K | 46,881 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,441 | $307.39 | $443K | 45,440 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,330 | $308.43 | $719K | 43,110 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −4,234 | $309.43 | $1.3M | 38,876 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,095 | $310.25 | $650K | 36,781 |
| 2025-08-21 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 77,000 | ||
| 2025-08-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-08-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,391 | $297.49 | $414K | 46,390 |
| 2025-08-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,353 | $298.73 | $404K | 45,037 |
| 2025-08-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,918 | $299.48 | $874K | 42,119 |
| 2025-08-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,837 | $300.47 | $852K | 39,282 |
Page 206 of 214 · 4,273 trades